Larimar Therapeutics Shares Are Trading Higher After Leerink Partners Initiated Coverage on the Stock With an Outperform Rating and $25 Price Target
Larimar Therapeutics的股价走高,此前Leerink Partners以跑赢大盘的评级和25美元的目标股价开始对该股进行报道
Larimar Therapeutics Shares Are Trading Higher After Leerink Partners Initiated Coverage on the Stock With an Outperform Rating and $25 Price Target
Larimar Therapeutics的股价走高,此前Leerink Partners以跑赢大盘的评级和25美元的目标股价开始对该股进行报道
使用浏览器的分享功能,分享给你的好友吧